BioNTech produces 10 times more antibodies than China's Sinovac: Study

BioNTech produces 10 times more antibodies than China's Sinovac: Study

HONG KONG: People who received BioNTech’s coronavirus vaccine had ten times the amount of antibodies than those given China’s Sinovac, a Hong Kong study has shown, adding to growing data on different jabs’ effectiveness.

© New Straits Times Press (M) Bhd

Scroll to Top